Dawei Technology (Guangdong) Group Past Earnings Performance
Past criteria checks 4/6
Dawei Technology (Guangdong) Group has been growing earnings at an average annual rate of 18.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 33.3% per year. Dawei Technology (Guangdong) Group's return on equity is 29%, and it has net margins of 44.7%.
Key information
18.8%
Earnings growth rate
27.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -33.3% |
| Return on equity | 29.0% |
| Net Margin | 44.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Optimistic Investors Push Guangdong Rongtai Industry Co.,Ltd (SHSE:600589) Shares Up 40% But Growth Is Lacking
Nov 08
Guangdong Rongtai Industry Co.,Ltd's (SHSE:600589) 30% Share Price Surge Not Quite Adding Up
Sep 24Guangdong Rongtai IndustryLtd (SHSE:600589) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Aug 29Guangdong Rongtai IndustryLtd (SHSE:600589) Has Debt But No Earnings; Should You Worry?
Aug 21Guangdong Rongtai Industry Co.,Ltd's (SHSE:600589) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jul 16Guangdong Rongtai Industry Co.,Ltd's (SHSE:600589) 28% Share Price Plunge Could Signal Some Risk
May 13Does Guangdong Rongtai IndustryLtd (SHSE:600589) Have A Healthy Balance Sheet?
Apr 26Guangdong Rongtai Industry Co.,Ltd's (SHSE:600589) Shares Climb 31% But Its Business Is Yet to Catch Up
Mar 04Revenue & Expenses Breakdown
How Dawei Technology (Guangdong) Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 395 | 176 | 100 | 16 |
| 30 Jun 24 | 387 | 124 | 98 | 16 |
| 31 Mar 24 | 375 | 128 | 93 | 16 |
| 31 Dec 23 | 367 | 83 | 94 | 16 |
| 30 Sep 23 | 395 | -720 | 400 | 17 |
| 30 Jun 23 | 288 | -779 | 383 | 14 |
| 31 Mar 23 | 313 | -773 | 397 | 14 |
| 31 Dec 22 | 421 | -745 | 400 | 15 |
| 30 Sep 22 | 285 | -834 | 241 | 15 |
| 30 Jun 22 | 536 | -768 | 205 | 21 |
| 31 Mar 22 | 702 | -720 | 198 | 36 |
| 31 Dec 21 | 780 | -719 | 202 | 37 |
| 30 Sep 21 | 1,139 | -1,279 | 588 | 63 |
| 30 Jun 21 | 1,165 | -1,240 | 639 | 60 |
| 31 Mar 21 | 1,126 | -1,238 | 618 | 49 |
| 31 Dec 20 | 1,069 | -1,226 | 625 | 50 |
| 30 Sep 20 | 1,119 | -918 | 236 | 40 |
| 30 Jun 20 | 1,175 | -913 | 254 | 47 |
| 31 Mar 20 | 1,306 | -644 | 255 | 53 |
| 31 Dec 19 | 1,428 | -624 | 257 | 58 |
| 30 Sep 19 | 1,561 | 343 | 153 | 53 |
| 30 Jun 19 | 1,621 | 375 | 147 | 51 |
| 31 Mar 19 | 1,681 | 151 | 156 | 55 |
| 31 Dec 18 | 1,700 | 154 | 150 | 52 |
| 30 Sep 18 | 1,780 | 161 | 116 | 45 |
| 30 Jun 18 | 1,754 | 155 | 86 | 64 |
| 31 Mar 18 | 1,688 | 138 | 87 | 46 |
| 31 Dec 17 | 1,643 | 134 | 94 | 39 |
| 30 Sep 17 | 1,532 | 119 | 91 | 28 |
| 30 Jun 17 | 1,520 | 116 | 120 | 0 |
| 31 Mar 17 | 1,472 | 104 | 125 | 0 |
| 31 Dec 16 | 1,437 | 101 | 119 | 0 |
| 30 Sep 16 | 1,187 | 74 | 70 | 0 |
| 30 Jun 16 | 1,085 | 50 | 79 | 0 |
| 31 Mar 16 | 1,000 | 36 | 60 | 0 |
| 31 Dec 15 | 994 | 21 | 62 | 0 |
| 30 Sep 15 | 1,007 | 12 | 12 | 0 |
| 30 Jun 15 | 1,077 | 16 | 10 | 0 |
| 31 Mar 15 | 1,183 | 27 | 9 | 0 |
| 31 Dec 14 | 1,190 | 31 | 5 | 0 |
| 30 Sep 14 | 1,240 | 36 | 52 | 0 |
| 30 Jun 14 | 1,216 | 42 | 61 | 0 |
| 31 Mar 14 | 1,180 | 53 | 68 | 0 |
| 31 Dec 13 | 1,186 | 55 | 67 | 0 |
Quality Earnings: 600589 has high quality earnings.
Growing Profit Margin: 600589 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600589 has become profitable over the past 5 years, growing earnings by 18.8% per year.
Accelerating Growth: 600589 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 600589 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 600589's Return on Equity (29%) is considered high.